Gibson Oncology, LLC — Form D
Gibson Oncology, LLC of MIAMI, FL, a company, filed a Form D exempt-offering notice with the SEC on 2024-10-31. The offering totals $4.7M, of which $3.8M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2024-10-31
- Form: D
- Accession: 0002042777-24-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $4.7M
- Amount sold: $3.8M
- Remaining: $925K
- Investors: 8
- Date of first sale: 2020-04-23
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-528250
Issuer
- Name: Gibson Oncology, LLC
- CIK: 0002042777
- Entity type: Limited Liability Company
- Jurisdiction: DELAWARE
- Address: 7772 FISHER ISLAND DRIVE, MIAMI, FL, 33109
- Phone: 502-345-8911
Officers, directors & promoters (11)
| Name | Role | Location |
|---|
| Mark Rogers | Director | Austin, TX |
| Mark Cushman | Director | Miami, FL |
| Clifford Solomon | Director | Miami, FL |
| Clifford Solomon | Executive Officer | Miami, FL |
| Elizabeth Rogers | Director | Miami, FL |
| Elizabeth Rogers | Executive Officer | Miami, FL |
| Theodore Solomon | Director | Miami, FL |
| Theodore Solomon | Executive Officer | Miami, FL |
| Randall Riggs | Director | Miami, FL |
| Randall Riggs | Executive Officer | Miami, FL |
| Mark Baganz | Director | Miami, FL |
Other filings by this issuer (1)
More